In pancreatic cancer, NFATc2 binding to p15 promoter recruits histone methyltransferase Suv39H1 resulting in H3K9 trimethylation, which allows docking of CBX3 to the repressor complex giving rise to p15 silencing [33]. Here, SUV39H1 is linked to pancreatic neoplasm.